BTㆍGTㆍNT INDUSTRY in SEOUL SEOUL METROPOLITAN GOVERNMENT BTㆍGTㆍNT INDUSTRY in SEOUL SEOUL METROPOLITAN GOVERNMENT Contents
Total Page:16
File Type:pdf, Size:1020Kb
ENGLISH BTㆍGTㆍNT INDUSTRY IN SEOUL SEOUL METROPOLITAN GOVERNMENT BTㆍGTㆍNT INDUSTRY IN SEOUL SEOUL METROPOLITAN GOVERNMENT Contents BTㆍGTㆍNT INDUSTRY IN SEOUL BT Industry 06 GT Industry 32 Incentives for the BTㆍNTㆍGT Industry 50 SEOUL METROPOLITAN GOVERNMENT The Global Biotechnology Industry 07 Global GT Industry 33 Tax Reduction/Exemption for BT GT Foreign-Invested Companies 51 Overview of the Korean Biotechnology Industry 09 Korea’s GT Industry 34 Market Size by Sector 11 Industry Trend 35 Major Industry’s Market Trend 12 GT Fields Given Priority by the INVEST 56 Seoul Metropolitan Government 39 Foreign Investment Process Industry Outlook and Investments 14 Business Activities of Foreign Foreign Investment in GT Industry 39 57 BT Labor Force 16 Companies in Korea Magok District 40 Government Support 17 Foreign Direct Investment Process 58 Competition 18 Nano Industry 42 The Biotechnology Industry in Seoul 20 Foreign Investment Incentives 60 Korea’s Nano Industry 43 Seoul’s BT Strategy 21 NT Land Support 61 Seoul’s Nano Industry 44 Success Story : Novartis Korea 22 Tax Support 61 Government Support Policy 44 Labor Cost of BT Industry 23 Cash Grant 62 New Growth Engine Hope Fund 45 Distribution of Biotechnology Companies in Seoul 24 Other Support 62 Gongneung District 46 Digital Media City 25 Foreign Investment Incentives 63 Magok District 48 Magok District 27 Support Organizations 64 Industry Overview BT Industry The Global Biotechnology Industry SEOUL METROPOLITAN GOVERNMENT SEOUL METROPOLITAN The global biotechnology market is expanding at a double-digit growth rate thanks to countries focusing their investments in biotechnology as the national strategic sector. This trend is expected to last for some time, as is continued growth with committed investments. BT Industry BTㆍGTㆍNT INDUSTRY IN SEOUL / SEOUL METROPOLITAN GOVERNMENT Biotechnology Industry’s World Market Outlook World market (100M USD) CAGR(%) 2005 2010 2015 2020 2005~2010 2010~2020 2005~2020 721 1,642 3,714 5,179 17.9 12.2 14.1 Source: 2010 Statistical Report on the Korean Biotechnology Industry; Korea BT Industry Association The biopharmaceutical market, which accounts for most of the biotechnology market, is expected to reach USD 189 billion by 2016, growing at a compound annual growth rate (CAGR) of 7.1% from 2009. Global sales from the United States’ and Europe’s antibody drugs take up 51.7% and 34.8%, respectively, adding up to 86.5% and a majority of the global market. Europe has officially announced the Antibody Biosimilar Guideline, implying its commercial feasibility, which, in turn, will trigger global competition for the biosimilar market. Antibody Drug Market Share (Unit: %) U.S. Europe Japan ROW Total Market share 51.7 34.8 5.8 7.7 100.0 Source: Hospira, Shinyoung Securities 7 컴퓨터 소프트웨어 18.2% 전기전자 제조 10.8% 컴퓨터 시스템 통합 9.9% 인터넷 9.8% 통신 7.9% 정보서비스 5.5% 컴퓨터 게임 5.0% 반도체 4.5% 모바일과 무선 4.2% 온라인 교육 3.1% 웹프로그램 3.0% 전자상거래 2.9% 컴퓨터 보안 2.6% 컴퓨터 네트워킹 2.5% 컴퓨터 하드웨어 2.5% 인터넷 매체 2.4% 가전 2.4% 웹디자인 1.6% 공장자동화 0.9% 애니메이션 0.4% BT Industry Biotechnology World Competitiveness Ranking Overview of the Korean Biotechnology Industry Biotechnology (BT) is a technology-intense, value- Ranking Score adding industry with a high proportion of research J#H# ' 39.04 and development (R&D) which requires original technologies. It is an industry many countries have 9ZcbVg` ( 31.85 adopted as their next growth engine, and governments HlZYZc ) 30.11 have implemented policies to support and foster it. 8VcVYV * Korea enacted the Life Science Support Law in 1983 29.26 GOVERNMENT SEOUL METROPOLITAN and implemented various policies to develop the BT 6jhigVa^V + 28.63 industry. Due to aggressive government policies, Hl^ioZgaVcY , 28.52 world-class technology developments, growing medical demand driven by an aging population and ;^caVcY - 28.41 increased market demand in biogenerics, Korea’s H^c\VedgZ . 27.90 BT industry is growing continuously. Its production J#@# / 26.75 market (local sales + export) reached USD 2.9 billion in 2006 and grew at an average annual rate of 18.2% to ;gVcXZ '& 26.66 ½ reach USD 5.6 billion in 2010. Aeh[W '/ 23.60 Source: Scientific American Korea’s BT Industry Market Size by Production (2006-2010) (Unit: million USD) AdXVaHVaZh :medgi AdXVaEgdYjXi^dcIdiVa 5,560 5,087 4,083 3,083 3,352 2,624 2,851 2,354 2,204 1,633 2,463 2,477 1,718 1,219 1,328 INDUSTRY IN SEOUL '%%+ '%%, '%%- '%%. '%&% GT GT · NT Source: 2010 Statistical Report on the Korean Biotechnology Industry; Korea BT Industry Association · BT 8 9 AdXVaHVaZh >bedgi AdXVa9ZbVcYIdiVa CAGR 15% 4,330 3,824 3,389 2,945 3,083 2,624 2,477 2,354 2,024 1,633 1,200 1,247 844 921 1,035 '%%+ '%%, '%%- '%%. '%&% CAGR 18.2% CAGR 15.0% AdXVaHVaZh :medgi AdXVaEgdYjXi^dcIdiVa 5,560 5,087 4,083 3,352 2,624 3,083 2,851 2,354 2,204 1,633 2,463 2,477 1,718 1,219 1,328 '%%+ '%%, '%%- '%%. '%&% BT Industry Local demand in Korea’s BT industry reached USD 2.5 billion in 2006. Growing at an average annual rate of Market Size by Sector 15%, it reached USD 4.3 billion in 2010. Creating about 22,000 jobs, the BT industry became one of Korea’s Supply and demand in Korea’s BT industry is as follows in the table. The pharmaceutical and food industries major industries. in 2010 accounted for approximately 77% of the market, followed by the chemical and resource industries. The pharmaceutical industry’s market share grew to 49.2% in 2009 from 38.6% in 2006, while the bio-food industry in the same period decreased from 43% to 27.7%. Clearly, technology-intensive industries like the Korea’s BT Industry Market Size by Demand (2006-2010) (Unit: million USD) biopharmaceutical industry are taking a bigger share of the production. AdXVaHVaZh >bedgi AdXVa9ZbVcYIdiVa SEOUL METROPOLITAN GOVERNMENT SEOUL METROPOLITAN CAGR 15% 4,330 Korea’s BT Production Size by Sector 3,824 (Unit: million USD) 3,389 2006 2007 2008 2009 2010 Growth rate 2,945 3,083 2,624 2,477 2,354 Pharmaceutical 1,101 1,521 1,827 2,249 2,184 19.67% 2,024 1,633 Food 1,227 1,188 1,224 1,407 2,138 14.85% 1,200 1,247 844 921 1,035 Chemical 183 211 250 298 569 42.19% Environment 147 181 193 206 100 -6.39% '%%+ '%%, '%%- '%%. '%&% Bioassay/ Bioinformatics 88 99 226 308 146 13.18% Source: 2010 Statistical Report on the Korean Biotechnology Industry; Korea BT Industry Association Others 105 152 351 364 423 60.57% Total 2,851 3,352 4,071 4,832 5,560 19.00% Source: 2010 Statistical Report on the Korean Biotechnology Industry; Korea BT Industry Association Korea’s BT Demand by Sector (Unit: million USD) CAGR 18.2%In addition, the Korean government and consistent 2006 2007 2008 2009 2010 Growth rate corporate investment in BT R&D are paying off, producing notable research results that are Pharmaceutical 1,543 1,857 2,085 2,289 2,410 11.24% CAGR 15.0% receiving worldwide attention. In particular, the Food 320 357 392 465 923 37.69% bioenergy industry, which grew more than 50% year Chemical 202 247 287 336 302 9.90% over year, resource industry, biochemical industry and bioelectronics industry will lead BT growth in Environment 147 179 186 198 97 -6.80% the coming years in local demand and the export Bioassay/ Bioinformatics 78 91 117 127 122 11.28% market. Others 187 215 321 409 476 30.91% INDUSTRY IN SEOUL GT GT Total 2,477 2,946 3,388 3,824 4,330 14.96% · NT · Source: 2010 Statistical Report on the Korean Biotechnology Industry; Korea BT Industry Association BT 10 11 14% 3% 6% 19% Antibiotics 8% Diag Veterinary Others 14% Anti-Cancer Drug 6% Diagnostic Kit Antibiotics Others 1% 14% 34% Alternative Treatment 3% 6% 19% Diag Veterinary Others 4% Antibiotics Vaccine 8% 14% Anti-Cancer 6% Drug Diag Veterinary Diagnostic Kit Antibiotics 19% 6% Blood Product Drug Others 1% Anti-Cancer 8% 34% Alternative Treatment1% BT Industry Diagnostic4% Kit Vaccine 6%Immune System Major Industry’s Market Trend DiagBio-Food Veterinary Industry 19% 3% 8% Blood Product DrugKorea’s bio-food industry, as well as that of Europe, Japan and the U.S., is in its developing stage,Anti-Cancer with the Alternative Treatment Hormone 8% Biopharmaceutical Industry number8% of patents6% rapidly increasing. The1% fast-growing market1%Hormone was valued at USD 2.1 billion in 34%Korea in 2010, Diagnostic Kit Immune System With the growing popularity of health-conscious with an annualBlood Product growth rate of 14.8% Immunefrom System USD 1.2 billion in 2006. Until 2009, the industry was stagnantVaccine in the 8% lifestyles, the synthetic drug market is on a decline. And USD3% 1.4 billion range. But it grew by a dramatic 51% in 2010 and has since shown rapid growth. Alternative Treatment Hormone 8% with the KFDA’s new, strict drug-approval policy, the 6% 1% Hormone 34% biopharmaceutical industry is gaining attention. In 2011, Blood Product Immune System Vaccine the government implemented a biopharmaceutical safety Bio-food Industry Market in Korea (2006-2010) (Unit: million USD) management policy and is working now to pass related SEOUL METROPOLITAN GOVERNMENT SEOUL METROPOLITAN policies. The biopharmaceutical industry, in terms of AdXVaEgdYjXi^dcIdiVa AdXVaHVaZh 2,138 production, recorded USD 1.1 billion in 2006. At an annual average growth rate of 18.7%, it grew to USD 2.2 billion in 1,407 1,227 1,224 2010.